Cyclin-Dependent Kinase 5 – An Emerging Player in Parkinson’s Disease Pathophysiology

QR Code

Cyclin-Dependent Kinase 5 – An Emerging Player in Parkinson’s Disease Pathophysiology

None

Saved in:

Bibliographic Details
Main Authors:	Cheung, Zelda H., Ip, Nancy Y.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/27848
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cyclin-Dependent Kinases (Cdk) as Targets for Cancer Therapy and Imaging
by: Graf, Franziska, et al.
Published: (2011)

PRACTICAL ASPECTS OF ADMINISTERING CYCLIN-DEPENDENT KINASES INHIBITORS: EFFICACY AND TOLERABILITY
by: E. V. Artamonova
Published: (2018-04-01)

CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER
by: E. N. Imyanitov, et al.
Published: (2017-12-01)

Hormone therapy for premenopausal women with metastatic breast cancer: combinations with cyclin-dependent kinase inhibitors
by: E. V. Artamonova, et al.
Published: (2019-09-01)

Cyclin-dependent kinase 5 negatively regulates antiviral immune response by disrupting myeloid differentiation primary response protein 88 self-association
by: Jian-Ping Ren, et al.
Published: (2023-12-01)

Current view of the inhibitor protein cyclin-dependent kinase р16, р27 and their role in the cell cycle
by: A. K. Aleksandrova, et al.
Published: (2016-02-01)

In Silico Characterization of a Cyclin Dependent Kinase -A (CDKA) and its Coding Gene in some Oryza Species
by: Ahmed Sayed Fouad, et al.
Published: (2020-07-01)

Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells
by: Girolamo Spagnoletti, et al.
Published: (2018-04-01)

CLINICAL PATHOPHYSIOLOGY OF PYRUVATE KINASE DEFICIENCY
by: Павел Павлович Поляков, et al.
Published: (2025-03-01)

THE USE OF PALBOCKLIB, A CYCLINE-DEPENDENT KINASE 4/6 INHIBITOR, IN THE TREATMENT OF METASTATIC BREAST CANCER. A COST-CONSEQUENCE ANALYSIS
by: S. L. Pavlinsky, et al.
Published: (2017-09-01)

Efficacy of cyclin-dependent kinases 4 and 6 inhibitors in the treatment of HR +/HER2 − advanced breast cancer: a meta-analysis
by: Isah Adamu Danbala, et al.
Published: (2025-06-01)

Exploring the Therapeutic Potential of Antiaris africana: Targeting Cyclin-Dependent Kinases 8 and 13 for Cancer Treatment through Molecular Docking Studies
by: Mutiu A. Alabi, et al.
Published: (2025-06-01)

Clinical and pathophysiological aspects of non-motor manifestations of Parkinson's disease
by: M. A. Nikitina, et al.
Published: (2020-01-01)

The role of microbiota dysbiosis in Parkinson’s disease: Pathophysiology and therapeutic opportunities
by: Shabnam Santos, et al.
Published: (2025-09-01)

Deletion of cyclin dependent kinase inhibitor 2a gene as a marker of oropharyngeal carcinomas non-associated with human papillomavirus and its prognostic value
by: I.S. Shponka, et al.
Published: (2024-06-01)

Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer
by: N. A. Avxentyev, et al.
Published: (2020-02-01)

Galectin 3: A new player in the pathogenesis of Parkinson’s disease
by: Juan García-Revilla, et al.
Published: (2026-03-01)

Pathophysiology of Non-Dopaminergic Monoamine Systems in Parkinson's Disease: Implications for Mood Dysfunction
by: Bhide, Nirmal, et al.
Published: (2011)

Pathophysiology of Protein Kinase C Isozymes in Chronic Lymphocytic Leukaemia
by: Allen, John C., et al.
Published: (2012)

Emerging Concepts Linking Mitochondrial Stress Signalling and Parkinson's Disease
by: Costa, Ana C., et al.
Published: (2012)

Regulation of the G1/S Transition in Adult Liver: Expression and Activation of the Cyclin Dependent Kinase Cdk1 in Differentiated Hepatocytes is Controlled by Extracellular Signals and is Crucial for Commitment to DNA Replication
by: Pascal, Loyer, et al.
Published: (2011)

Effectiveness of cyclin-dependent kinase 4 and 6 inhibitors for the treatment of hormonesensitive HER2-negative metastatic breast cancer in first-line therapy: A systematic literature review
by: N. A. Avxentyev, et al.
Published: (2024-05-01)

ROLE OF CYCLIN D1 IN THE MECHANISMS OF TAMOXIFEN RESISTANCE
by: D. B. Erdyneeva, et al.
Published: (2020-09-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease Complicated by Diabetes: Pathophysiology and Emerging Therapies
by: Hisanori Goto, et al.
Published: (2025-07-01)

Long non-coding RNA colon cancer–associated transcript 1 functions as a competing endogenous RNA to regulate cyclin-dependent kinase 1 expression by sponging miR-490-3p in hepatocellular carcinoma progression
by: Chunqing Dou, et al.
Published: (2017-04-01)

On the Specialization History of the ADP-Dependent Sugar Kinase Family
by: Merino, Felipe, et al.
Published: (2011)

Parkin and Parkinson’s Disease
by: Tay, Shiam-Peng, et al.
Published: (2011)

Myeloid and Lymphoid Malignancies with Fusion Kinases Involving Spleen Tyrosine Kinase (SYK)—Emerging Rare Entities?
by: Velizar Shivarov, et al.
Published: (2025-06-01)

Prognostic Value of Cyclin D1 Overexpression in Invasive Breast Carcinoma
by: Funda Taşlı, et al.
Published: (2025-04-01)

The impact of cyclin D1 on endometrial hyperplasia and endometrioid endometrial carcinoma
by: Sudha M, et al.
Published: (2025-06-01)

cGMP-Dependent Protein Kinase in the Regulation of Cardiovascular Functions
by: Gao, Yuansheng, et al.
Published: (2012)

Pathophysiology of Late Onset Alzheimer Disease
by: Isik, Ahmet Turan, et al.
Published: (2011)

Pharmacological methods of therapy in Parkinson’s disease
by: Y. N. Bykov, et al.
Published: (2016-05-01)

Update in Parkinson’s Disease
by: Carrillo, Fátima, et al.
Published: (2012)

Pesticides and Parkinson’s Disease
by: Fitzmaurice, Arthur G., et al.
Published: (2011)

Genetics of Parkinson Disease
by: Sassi, Celeste
Published: (2011)

Pesticides and Parkinson’s Disease
by: Janelle, Drouin-Ouellet, et al.
Published: (2011)

Apraxia in Parkinson’s disease
by: E. G. Antonen, et al.
Published: (2021-06-01)

Activity-Dependent Regulation of the Dopamine Phenotype in the Adult Substantia Nigra: Prospects for Treating Parkinson's Disease
by: Horne, Mal, et al.
Published: (2012)

Kinase-dependent regulation of ciliary protein transport and its implications for therapy
by: Taro Chaya, et al.
Published: (2025-06-01)